Patents : |  |
| US Patent No. | Title |
| 7598232 | Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
|
| 7601724 | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
| 7601855 | Substituted chroman derivatives, medicaments and use in therapy
|
| 7604805 | Protein logic gates
|
| 7604991 | Method of generating islet beta-cells from exocrine pancreatic cells
|
| 7605131 | EML4-ALK fusion gene
|
| 7605138 | Nucleic acid compositions for stimulating immune responses
|
| 7605154 | Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
|
| 7605155 | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
| 7605160 | Pyrrolotriazine kinase inhibitors
|
| 7605167 | Use of cyclopamine in the treatment of psoriasis
|
| 7601703 | Enzyme catalyzed therapeutic agents
|
| 7601697 | Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
| 7598257 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
| 7598263 | Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
|
| 7598272 | Kinase inhibitors
|
| 7598283 | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
| 7598350 | Human anti-epidermal growth factor receptor antibody
|
| 7598369 | siRNA targeting histamine receptor H1
|
| 7598370 | siRNA targeting polo-like kinase-1 (PLK-1)
|
| 7601335 | Pretreatment of a biological sample from an autoimmune disease subject
|
| 7601355 | Compositions and methods for altering immune function
|
| 7601514 | Nucleic acid encoding PRO10268 polypeptides
|
| 7605229 | PRO87299 polypeptides
|
| 7605250 | siRNA targeting cAMP-specific phosphodiesterase 4D
|
| 7605252 | siRNA targeting kinase insert domain receptor (KDR)
|
| 7612042 | Methods for inhibiting heregulin and treating cancer
|
| 7612063 | Substituted quinobenzoxazine analogs
|
| 7612077 | Crystalline forms of the anti-cancer compound ZD1839
|
| 7612084 | Amine derivatives for the treatment of asthma and COPD
|
| 7612092 | Nitrogen-containing aromatic derivatives
|
| 7612172 | Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7612180 | Humanized L243 antibodies
|
| 7612181 | Dual variable domain immunoglobulin and uses thereof
|
| 7612196 | siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
|
| 7611893 | Metal-binding therapeutic peptides
|
| 7611839 | Methods for diagnosing RCC and other solid tumors
|
| 7608260 | Stabilized immunoglobulins
|
| 7608269 | Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
|
| 7608286 | Phyto-nutraceutical synergistic composition for hyperlipedemic condition
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7608706 | siRNA targeting ras-related nuclear protein
|
| 7608707 | siRNA targeting survivin
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7611072 | Method and device for atomizing liquid
|
| 7611711 | VEGFR-3 inhibitor materials and methods
|
| 7612200 | Inhibitors of protein kinases
|
